Karolinska Development AB ser. B - Asset Resilience Ratio

Latest as of December 2025: 0.88%

Karolinska Development AB ser. B (KDEV) has an Asset Resilience Ratio of 0.88% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Karolinska Development AB ser. B total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

Skr9.27 Million

≈ $997.92K USD Cash + Short-term Investments

Total Assets

Skr1.05 Billion

≈ $113.34 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2008–2025)

This chart shows how Karolinska Development AB ser. B's Asset Resilience Ratio has changed over time. See KDEV book value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Karolinska Development AB ser. B's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Karolinska Development AB ser. B (KDEV) market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Skr0.00	0%
Short-term Investments	Skr9.27 Million	0.88%
Total Liquid Assets	Skr9.27 Million	0.88%

Asset Resilience Insights

Limited Liquidity: Karolinska Development AB ser. B maintains only 0.88% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Karolinska Development AB ser. B Industry Peers by Asset Resilience Ratio

Compare Karolinska Development AB ser. B's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Argen-X F:1AE	Biotechnology	25.67%
Tubize-Fin BR:TUB	Biotechnology	0.05%
BrightGene Bio Medical Technology C SHG:688166	Biotechnology	1.00%
Dashenlin Pharm Grp Co Ltd SHG:603233	Biotechnology	0.02%
Staidson Beijing Biopharma SHE:300204	Biotechnology	7.93%
Tibet Cheezheng Tibetan Medicine Co Ltd SHE:002287	Biotechnology	41.25%
Ardelyx Inc NASDAQ:ARDX	Biotechnology	41.14%
Xiangxue Pharmaceutical SHE:300147	Biotechnology	0.05%

Annual Asset Resilience Ratio for Karolinska Development AB ser. B (2008–2025)

The table below shows the annual Asset Resilience Ratio data for Karolinska Development AB ser. B.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	0.88%	Skr9.27 Million ≈ $997.92K	Skr1.05 Billion ≈ $113.34 Million	-3.36pp
2024-12-31	4.24%	Skr53.09 Million ≈ $5.71 Million	Skr1.25 Billion ≈ $134.73 Million	-3.36pp
2023-12-31	7.60%	Skr95.66 Million ≈ $10.29 Million	Skr1.26 Billion ≈ $135.42 Million	-8.84pp
2022-12-31	16.44%	Skr205.79 Million ≈ $22.15 Million	Skr1.25 Billion ≈ $134.70 Million	+8.11pp
2021-12-31	8.33%	Skr92.40 Million ≈ $9.94 Million	Skr1.11 Billion ≈ $119.38 Million	-4.82pp
2020-12-31	13.15%	Skr117.05 Million ≈ $12.60 Million	Skr890.08 Million ≈ $95.79 Million	+3.31pp
2019-12-31	9.84%	Skr114.75 Million ≈ $12.35 Million	Skr1.17 Billion ≈ $125.56 Million	-7.64pp
2018-12-31	17.48%	Skr138.85 Million ≈ $14.94 Million	Skr794.38 Million ≈ $85.49 Million	-8.10pp
2017-12-31	25.58%	Skr169.63 Million ≈ $18.26 Million	Skr663.26 Million ≈ $71.38 Million	-31.04pp
2016-12-31	56.61%	Skr248.15 Million ≈ $26.70 Million	Skr438.32 Million ≈ $47.17 Million	+11.43pp
2015-12-31	45.19%	Skr277.65 Million ≈ $29.88 Million	Skr614.46 Million ≈ $66.13 Million	+37.68pp
2014-12-31	7.51%	Skr128.44 Million ≈ $13.82 Million	Skr1.71 Billion ≈ $184.06 Million	-1.21pp
2013-12-31	8.72%	Skr165.33 Million ≈ $17.79 Million	Skr1.90 Billion ≈ $204.01 Million	+0.86pp
2012-12-31	7.86%	Skr174.16 Million ≈ $18.74 Million	Skr2.21 Billion ≈ $238.37 Million	-11.63pp
2011-12-31	19.49%	Skr457.25 Million ≈ $49.21 Million	Skr2.35 Billion ≈ $252.45 Million	+11.79pp
2010-12-31	7.70%	Skr136.61 Million ≈ $14.70 Million	Skr1.77 Billion ≈ $190.87 Million	+1.75pp
2009-12-31	5.95%	Skr121.39 Million ≈ $13.06 Million	Skr2.04 Billion ≈ $219.38 Million	-12.13pp
2008-12-31	18.09%	Skr301.00 Million ≈ $32.39 Million	Skr1.66 Billion ≈ $179.08 Million	--

pp = percentage points

About Karolinska Development AB ser. B

ST:KDEV Sweden Biotechnology

Market Cap

$29.36 Million

Skr272.85 Million SEK

Market Cap Rank

#23785 Global

#467 in Sweden

Share Price

Skr0.29

Change (1 day)

+0.00%

52-Week Range

Skr0.25 - Skr1.08

All Time High

Skr10.82